Many life science companies face very specific challenges: molecular diagnostic models have completed validation, yet they struggle to find hospital departments willing to run pilot trials; cell and gene therapy pipelines reach the pre-clinical stage, but the door to pharma partnerships remains closed; having just closed one financing round, they wonder where to source industrial capital for the next. Such pain points — possessing solid technology but lacking real-world scenarios and access channels — can hardly be resolved by enterprises working alone. For life science firms, what is truly scarce is not a one-time appearance at an exhibition, but a matchmaking gateway that brings clinical institutions, pharmaceutical companies, investors and industrial supply chains into one venue.

The Life Science & Healthcare track at Hongqiao Tech Week, combined with planned targeted one-on-one business matchmaking and local medical resources within the Yangtze River Delta, creates exactly this connection platform for such enterprises. It is not merely a blanket showcase; it enables early R&D, application and hardware-focused companies to meet the right decision-makers in dedicated meeting sessions.

Coverage of the Life Science & Healthcare Track

Life Science & Healthcare is one of Hongqiao Tech Week’s six core technology tracks. Its exhibit categories cover biotechnology, cell and gene therapy, AI medical applications (AI diagnostics, AI-assisted diagnosis, AI-driven new drug R&D, etc.), digital therapeutics, smart hospital solutions, internet hospitals, high-end medical devices, and cutting-edge topics such as brain-computer interfaces (subject to official exhibit classification).

This means no matter where you sit along the industrial chain, you can find your place: early-stage gene therapy teams can present their targets and clinical value at industry forums; medical imaging AI and digital therapeutics firms can allow buyers to test their solutions directly via booth demonstrations; high-end medical device manufacturers can gain exposure from hospitals and distribution channels by showcasing products in realistic usage scenarios. Clarify your niche first, then decide between booth display, forum speaking or matchmaking meetings — this will greatly boost preparation efficiency.

Who Life Science Enterprises Can Meet On-site

At Hongqiao Tech Week, life science exhibitors can connect with at least four stakeholder groups, each addressing distinct business needs:

  1. Hospitals & Medical Groups: Ideal for pitching smart hospital solutions and department-level requirements. If your goal is to launch clinical pilots, access to specific departments is subject to participating institutions and official arrangements. For products requiring real-world data, these stakeholders represent the closest access to real clinical scenarios.
  2. Pharmaceutical & Biotech Companies: Suitable for licensing, joint R&D and pipeline collaboration. For platform and tool-based enterprises, pharma business development (BD) teams serve as primary collaboration entry points.
  3. Medical Industry Funds & Pharma Corporate Venture Capital Divisions: For growth-stage and follow-on financing, especially when your product has secured key validation and requires follow-up capital.
  4. Yangtze River Delta Industrial Parks & High-End Manufacturing Suppliers: To transfer technologies into scalable production supply chains, solving manufacturing and roll-out challenges from prototypes to large-scale deployment.

Clearly define your priority contacts, and the matchmaking team can pre-invite relevant buyers, BD representatives and partners instead of organising casual introductions.

Turning Technology into Partnerships: Combine Three Engagement Mechanisms

Life science products feature long commercialisation cycles and complex decision-making workflows. A standalone booth is rarely sufficient. A more effective approach combines three mechanisms:

  1. Planned 2,000+ targeted one-on-one business meetings: Pre-match hospital procurement teams, pharma BD representatives and investment partners according to your corporate objectives, shifting from random encounters to curated introductions.
  2. Life Science & Healthcare Industry Forum: A stage to articulate clinical value and business models before peers and decision-makers, helping build professional credibility. Confirmed speakers include Zhu Yuchao, General Manager of Hanxin Biotech (Suzhou); Lai Caida, Founder & Chairman of Mytide Therapeutics; Shen Qiancheng, Co-founder & Chairman of UD Bio; Gao Jianxiong, Vice President of Smart Health Cloud Platform Division, Aikang Group; and Yang Bin, Vice Chair of Digital & AI Practice Community, ISPE China.
  3. Booth & On-site Demonstrations: Allow prototypes, equipment and software to be viewed and tested in realistic usage scenarios, completing the on-site validation phase.

These three mechanisms correspond to curated introductions, industry thought leadership and hands-on product validation. Used together, they form a complete business connection pipeline.

Why the Yangtze River Delta & Hongqiao

Life science translation relies heavily on clinical resources, manufacturing support and payer ecosystems — all of which are densely concentrated in the Yangtze River Delta. Public regional industrial data shows the Hongqiao International Central Business District hosts over 7,000 digital economy enterprises, 3,600 automotive supply-chain companies and 1,000 new-energy firms. Medical groups, pharmaceutical enterprises and advanced manufacturing infrastructure within the region provide nearby industrial chains and real-world scenarios for life science products to scale from prototypes to commercial application.

Preparation Priorities for Different Sub-sectors

The life science sector is broad, and promotional materials should be tailored to your niche:

Prepare verifiable evidence, and matchmaking and forum conversions will be far smoother.

Two Perspectives for International Life Science Enterprises

For overseas teams, Hongqiao Tech Week delivers dual opportunities: entering the China market and leveraging its global network for international expansion. Drawing on affiliated global platforms, it brings overseas enterprises, venture capitalists and tech innovation decision-makers, enabling dual validation of technology and business models within the Chinese market. Meanwhile, medical groups, pharmaceutical firms and advanced manufacturing capacity in the Yangtze River Delta offer local support for scaling products from prototypes. Before exhibiting, clarify your core objective: whether you seek hospital and department connections, pharma collaboration, or local manufacturing and distribution channels. Different goals require completely different sets of outreach materials.

Organiser Background & Resource Ecosystem

Brief overview of hosting structure: Guided by the Hongqiao International Central Business District Administrative Committee, Shanghai Municipal Commission of Commerce and Shanghai Science and Technology Commission, Hongqiao Tech Week is hosted by Informa Group, with Shanghai Science and Technology Entrepreneurship Center as its strategic innovation partner and GEC as its strategic partner. The event runs from 20 to 22 November 2026 at the National Exhibition and Convention Center (Shanghai). Built on the established London Tech Week brand and Informa’s global tech event portfolio, it connects overseas enterprises, VC firms and tech innovators to the Chinese market as a comprehensive industry-focused tech festival. For life science and healthcare companies, this means clinical demand, industrial capital and overseas partners can all be accessed within one single event.

It shares the same global tech event ecosystem as London Tech Week, Africa Tech Festival and ATxEnterprise in Singapore, with shared pools of overseas enterprises, VC and innovation decision-makers. These are accumulated resources from the organiser and do not constitute the event’s own scale. Confirmed international pavilions and global speaker resources also create opportunities for cross-border collaboration and global expansion for life science exhibitors.

Visitor registration data as of 23 August 2026 shows 32.6% of registered attendees have confirmed procurement budgets; 67.7% are mid-to-high budget buyers (budget above RMB 50,000); and 54.8% intend to source procurement, channel and partnership opportunities via business matchmaking. This means life science exhibitors will meet professional buyers with budgets and decision-making authority, rather than casual visitors.

Three Pre-Event Preparation Recommendations

If your team is searching for clinical pilot opportunities, pharma partnerships or growth-stage capital for Hongqiao Tech Week, complete three preparation tasks first:

  1. Prepare a one-page company profile outlining your technology, target indications and completed validation results.
  2. List your top 10 target stakeholder categories (hospital departments, pharma BD teams, fund types).
  3. Submit your exhibition intent via the official website hongqiaotechweek.com and request the exhibitor roadmap and matchmaking guidelines for the Life Science & Healthcare track. Early preparation will greatly improve the precision of on-site meetings.

FAQ

Q: Upstream and downstream industrial resources can life science exhibitors connect with at Hongqiao Tech Week? A: Hongqiao Tech Week connects life science firms with four categories of stakeholders: hospitals and medical groups, pharmaceutical and biotech companies, medical industry funds and corporate venture capital divisions, plus industrial parks and high-end manufacturing suppliers across the Yangtze River Delta. Most importantly, the planned 2,000+ targeted one-on-one business matchmaking sessions can pre-match specific contacts aligned with your objectives, instead of waiting for visitors to pass your booth. Teams aiming to advance clinical, BD and fundraising pipelines simultaneously can meet key contacts all in one event.

Q: Will hospitals and pharmaceutical companies attend? A: Yes. The Life Science & Healthcare track is specifically designed for this type of connection, with hospital procurement teams, pharma BD representatives and industrial capital included in the invitation list. The confirmed speaker lineup features industry representatives including Zhu Yuchao, General Manager of Hanxin Biotech (Suzhou); Lai Caida, Founder & Chairman of Mytide Therapeutics; Shen Qiancheng, Co-founder & Chairman of UD Bio; and Gao Jianxiong, Vice President of Smart Health Cloud Platform Division, Aikang Group. Final attending organisations and rosters are subject to the latest official release.

Q: Can I conduct product demonstrations or trials on-site? A: Yes, and this is one of the key values of the Life Science & Healthcare track. Both booths and forums support product demos and hands-on trials. Buyers can directly test prototypes, equipment and software in realistic scenarios, so on-site validation does not need to wait until after the show. Presentation of clinically relevant content must comply with applicable regulatory requirements; confirm boundaries with the organising team in advance.

Q: Are early-stage life science startups suitable to apply for startup booths? A: Worth consideration. Startup booths under the Startup Ecosystem track have lower entry barriers for early and mid-stage teams, while granting access to medical industry funds and pharma corporate venture capital divisions. If you have a small team and want high exposure and capital connections at a lower cost, this option is more cost-effective than standard booths. Application criteria can be confirmed with the organising team.

Q: Can international life science enterprises enter the China market through this event? A: It can serve as a market-entry gateway. Leveraging the London Tech Week ecosystem, Hongqiao Tech Week brings overseas enterprises, VC firms and innovation decision-makers. Confirmed international pavilions include Germany De:Hub, Enterprise Ireland, AICEP Portugal Global, Saudi Investment Ministry and UK Department for International Trade. For international teams, it enables technology validation and local partnership development within the China market in one place.

Q: What do clinical and manufacturing resources in the Yangtze River Delta mean for life science companies? A: It means a shorter path from prototype to large-scale commercialisation. Public regional industrial data shows the Hongqiao International Central Business District hosts over 7,000 digital economy enterprises, 3,600 automotive supply-chain firms and 1,000 new-energy companies. Medical groups, pharmaceutical firms and advanced manufacturing infrastructure within the region help enterprises source suppliers, real-world scenarios and payers locally. Hongqiao Tech Week aggregates these resources in one venue, delivering long-term value beyond a single exhibition exposure.